Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Viking Therapeutics, Inc. (VKTX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -55.0-39.5-25.8-22.1-20.6-14.7-23.4-21.9
Stock-based compensation  6.15.83.72.61.51.82.60.0
Change in working capital   [+]13.718.22.39.80.45.20.70.3
Other operating activities  -12.4-6.3-5.1-9.13.9-3.311.420.0
Cash from operations  -47.6-21.8-24.8-18.8-14.8-11.1-8.7-1.6
   
Capital expenditures  0.00.00.00.00.00.00.00.0
Sales of short-term investments       20.02.6 
Other cash from investing  38.041.67.5-265.7-1.7-16.9-16.0 
Cash from investing  38.041.67.5-265.7-1.73.0-13.50.0
   
Issuance of common stock, net     296.622.411.525.40.0
Other cash from financing  6.91.00.93.70.0-1.2-3.22.2
Cash from financing  6.91.00.9300.322.410.322.22.2
   
Free cash flow  -47.6-21.8-24.8-18.8-14.8-11.1-8.7-1.6
        Per share (diluted)  ($0.62)($0.30)($0.34)($0.33)($0.57)($0.68)($1.37)($0.38)
   
Cash paid for interest     0.10.10.2  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy